Learn More
Cell Sciences Inc Research Grade Alnuctamab, Trivalent Bispecific Monoclonal Antibody, 1.0 mg
Supplier: Cell Sciences Inc DHF92403B
Research Grade Alnuctamab is a trivalent, bispecific humanized monoclonal antibody designed for laboratory research applications. It uniquely targets human BCMA and CD3e, facilitating T-cell-mediated targeting, making it an advanced reagent for enhanced research results. Provided in a quantity of 1.0 mg, it ensures optimal performance across various research protocols, delivering stability for up to 1 year.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.